Added to YB: 2025-07-10
Pitch date: 2025-05-20
ENZB [bullish]
Enzo Biochem, Inc.
+27.07%
current return
Author Info
No bio for this author
Company Info
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.
Market Cap
$35.7M
Pitch Price
$0.55
Price Target
1.14 (+63%)
Dividend
14.68%
EV/EBITDA
-0.21
P/E
-4.53
EV/Sales
0.07
Sector
Life Sciences Tools and Services
Category
special_situation
Enzo Biochem, Inc. - $ENZB
ENZB: Special situation with $30M Life Sciences + $10-15M real estate vs $30M mkt cap & $28M net cash. Activist-controlled board pursuing sale after multiple inquiries. Wolf dissent ($3.50/sh) & cash burn ($2M/qtr) are key risks. Midpoint valuation $1.14/sh (96% upside) w/ $0.52 floor.
Read full article (8 min)